Andrew Miller Profile
Andrew Miller

@AndyMillerLab

Followers
148
Following
53
Media
5
Statuses
65

Joined April 2022
Don't wanna be here? Send us removal request.
@AndyMillerLab
Andrew Miller
5 months
Advancing an Inflammatory Subtype of Depression. The time has come to disentangle the heterogeneity of depression and develop targeted therapies for mechanism-based entities. Read more at https://t.co/wHPZnc1Xi9 #depression #mentalhealth #PNIRS2025
Tweet card summary image
news.emory.edu
Researchers at Emory University have provided compelling evidence supporting the existence of an inflammatory subtype of major depression, a breakthrough that could transform how this complex...
1
4
14
@AndyMillerLab
Andrew Miller
7 months
Identifying and treating specific clinical outcomes like anhedonia in depression is the next step in developing targeted therapies in psychiatry…Unfortunately, this will be a challenge with many failures along the way…#Depresion #MentalHealth
0
3
4
@AndyMillerLab
Andrew Miller
7 months
Identifying and treating specific clinical outcomes like anhedonia in depression is the next step in developing targeted therapies in psychiatry…Unfortunately, this will be a challenge with many failures along the way…#Depresion #MentalHealth
0
3
4
@BIEmory
Emory Behavioral Immunology Program
10 months
Immunopsychiatry can lead the way for targeted treatments and precision medicine in psychiatry...Check out a recent paper summarizing our discussions from an international forum in Crans-Montana, Switzerland... https://t.co/VSt3a2Vz6Z #depression #inflammation #mentalhealth
0
2
3
@theaspirestudy
ASPIRE
1 year
Work package 6 is being led by @AndyMillerLab, @MondelliValeria, Prof. Dan Stein, @LeboyerMarion and @BiopsyLab, who are are leading a 12-week study to test our decision tool for people with #depression who aren't responding to #antidepressants. Exciting steps ahead!🧠
1
3
6
@theaspirestudy
ASPIRE
1 year
@BenedettaVai & @LiviaDePicker are leading work package 1 in groundbreaking #research on #inflammation related clinical predictors. They are performing a systematic review and meta-analysis to look at previous results and uncover new insights.
2
4
9
@theaspirestudy
ASPIRE
1 year
@LamersFemke @Lombardo_GG In work package 4, led by Francesco Benedetti & Jennifer Felger, we’re investigating if brain scans can predict how #depression patients respond to anti-inflammatory treatments! By analysing data from three trials, we aim to uncover brain markers linked to #inflammation.
1
2
6
@theaspirestudy
ASPIRE
1 year
Exciting work ahead with @LamersFemke and @Lombardo_GG leading WP3! They’ll explore how blood biomarkers can predict clinical improvement in #depression after #antiinflammatory treatment through meta-analysis.
1
4
5
@theaspirestudy
ASPIRE
1 year
Our team is busy building strong links between work packages to ensure every step of the process leads to meaningful results! 🔬✨ Have a look at our #PlanofWork with our pathways of #impact:
0
3
7
@BIEmory
Emory Behavioral Immunology Program
1 year
More data on the link between depression and inflammation. The time has come for an inflammation specifier for depression. Check this out https://t.co/9c6yMKTbWY #inflammation #mentalhealth #depression
0
3
3
@BIEmory
Emory Behavioral Immunology Program
1 year
As illustrated, the #PNIRS24 sign was a hit among banquet-goers 😉
0
2
7
@BIEmory
Emory Behavioral Immunology Program
1 year
A fantastic end to #PNIRS24 🎆🎇🎆 Congrats to Jennifer Felger on delivering such an impactful Solomon award lecture!
0
3
5
@BIEmory
Emory Behavioral Immunology Program
1 year
Genevieve Craig and @MandyBekhbat present their work in depression #PNIRS24
0
3
10
@BIEmory
Emory Behavioral Immunology Program
1 year
Inflammation, Glia, and Glutamate converge to drive both Depression and Neurodegeneration: Check out Dr. Ebrahim Haroon's full talk here:
vumedi.com
A video from Conference Highlights, posted on May 22, 2024.
0
2
2
@AndyMillerLab
Andrew Miller
2 years
Our work featured on PBS “Your Fantastic Mind”…Check it out… https://t.co/2ir2kqQxIG #depression #inflammation #mentalhealth
1
5
15
@vmarconi2
Vince Marconi
2 years
New findings from Emory study offer potential breakthrough in HIV cure research | Emory University | Atlanta GA https://t.co/0FYJ6t4iJu @GavegnanoGroup @MonicaReece @drugbuster21 @CarlosdelRio7 @Boghuma
0
7
17
@WIRED
WIRED
2 years
A sixth person, dubbed the “Geneva patient,” may be free of HIV after receiving a stem cell transplant intended to treat another disease—his cancer. Is an anti-inflammatory drug behind his recovery, instead?
wired.com
Five people went into viral remission after stem cell transplants from donors with HIV resistance. A sixth patient received normal cells. Is an anti-inflammatory drug behind his recovery, instead?
0
23
47